157 related articles for article (PubMed ID: 32713609)
21. Progressive brainstem pathology in motor neuron diseases: Imaging data from amyotrophic lateral sclerosis and primary lateral sclerosis.
Bede P; Chipika RH; Finegan E; Li Hi Shing S; Chang KM; Doherty MA; Hengeveld JC; Vajda A; Hutchinson S; Donaghy C; McLaughlin RL; Hardiman O
Data Brief; 2020 Apr; 29():105229. PubMed ID: 32083157
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal imaging in
Floeter MK; Bageac D; Danielian LE; Braun LE; Traynor BJ; Kwan JY
Neuroimage Clin; 2016; 12():1035-1043. PubMed ID: 27995069
[TBL] [Abstract][Full Text] [Related]
23. C9orf72 ALS mutation carriers show extensive cortical and subcortical damage compared to matched wild-type ALS patients.
Nigri A; Umberto M; Stanziano M; Ferraro S; Fedeli D; Medina Carrion JP; Palermo S; Lequio L; Denegri F; Agosta F; Filippi M; Valentini MC; Canosa A; Calvo A; Chiò A; Bruzzone MG; Moglia C
Neuroimage Clin; 2023; 38():103400. PubMed ID: 37068310
[TBL] [Abstract][Full Text] [Related]
24. Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality.
Bede P; Bokde A; Elamin M; Byrne S; McLaughlin RL; Jordan N; Hampel H; Gallagher L; Lynch C; Fagan AJ; Pender N; Hardiman O
J Neurol Neurosurg Psychiatry; 2013 Jul; 84(7):766-73. PubMed ID: 23085933
[TBL] [Abstract][Full Text] [Related]
25. Basal ganglia pathology in ALS is associated with neuropsychological deficits.
Machts J; Loewe K; Kaufmann J; Jakubiczka S; Abdulla S; Petri S; Dengler R; Heinze HJ; Vielhaber S; Schoenfeld MA; Bede P
Neurology; 2015 Oct; 85(15):1301-9. PubMed ID: 26385880
[TBL] [Abstract][Full Text] [Related]
26. Cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: A two-centre tract of interest-based DTI analysis.
Müller HP; Agosta F; Gorges M; Kassubek R; Spinelli EG; Riva N; Ludolph AC; Filippi M; Kassubek J
Neuroimage Clin; 2018; 20():1062-1069. PubMed ID: 30343251
[TBL] [Abstract][Full Text] [Related]
27. Region-specific atrophy of precentral gyrus in patients with amyotrophic lateral sclerosis.
Qin Y; Zhang S; Jiang R; Gao F; Tang X; Zhu W
J Magn Reson Imaging; 2018 Jan; 47(1):115-122. PubMed ID: 28591490
[TBL] [Abstract][Full Text] [Related]
28. Focal alterations of the callosal area III in primary lateral sclerosis: An MRI planimetry and texture analysis.
Müller HP; Dreyhaupt J; Roselli F; Schlecht M; Ludolph AC; Huppertz HJ; Kassubek J
Neuroimage Clin; 2020; 26():102223. PubMed ID: 32114375
[TBL] [Abstract][Full Text] [Related]
29. Neuroimaging patterns along the ALS-FTD spectrum: a multiparametric imaging study.
Omer T; Finegan E; Hutchinson S; Doherty M; Vajda A; McLaughlin RL; Pender N; Hardiman O; Bede P
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):611-623. PubMed ID: 28562080
[TBL] [Abstract][Full Text] [Related]
30. Gray matter and white matter changes in non-demented amyotrophic lateral sclerosis patients with or without cognitive impairment: A combined voxel-based morphometry and tract-based spatial statistics whole-brain analysis.
Christidi F; Karavasilis E; Riederer F; Zalonis I; Ferentinos P; Velonakis G; Xirou S; Rentzos M; Argiropoulos G; Zouvelou V; Zambelis T; Athanasakos A; Toulas P; Vadikolias K; Efstathopoulos E; Kollias S; Karandreas N; Kelekis N; Evdokimidis I
Brain Imaging Behav; 2018 Apr; 12(2):547-563. PubMed ID: 28425061
[TBL] [Abstract][Full Text] [Related]
31. Role of the nigrosome 1 absence as a biomarker in amyotrophic lateral sclerosis.
Moreno-Gambín MI; Tembl JI; Mazón M; Cañada-Martínez AJ; Martí-Bonmatí L; Sevilla T; Vázquez-Costa JF
J Neurol; 2022 Mar; 269(3):1631-1640. PubMed ID: 34379200
[TBL] [Abstract][Full Text] [Related]
32. Structural explanation of poor prognosis of amyotrophic lateral sclerosis in the non-demented state.
Kim HJ; Oh SI; de Leon M; Wang X; Oh KW; Park JS; Deshpande A; Buj M; Kim SH
Eur J Neurol; 2017 Jan; 24(1):122-129. PubMed ID: 27753163
[TBL] [Abstract][Full Text] [Related]
33. Cortical markers of cognitive syndromes in amyotrophic lateral sclerosis.
Consonni M; Contarino VE; Catricalà E; Dalla Bella E; Pensato V; Gellera C; Lauria G; Cappa SF
Neuroimage Clin; 2018; 19():675-682. PubMed ID: 30023173
[TBL] [Abstract][Full Text] [Related]
34. The segmental diffusivity profile of amyotrophic lateral sclerosis associated white matter degeneration.
Schuster C; Elamin M; Hardiman O; Bede P
Eur J Neurol; 2016 Aug; 23(8):1361-71. PubMed ID: 27207250
[TBL] [Abstract][Full Text] [Related]
35. Toward a marker of upper motor neuron impairment in amyotrophic lateral sclerosis: A fully automatic investigation of the magnetic susceptibility in the precentral cortex.
Contarino VE; Conte G; Morelli C; Trogu F; Scola E; Calloni SF; Sanmiguel Serpa LC; Liu C; Silani V; Triulzi F
Eur J Radiol; 2020 Mar; 124():108815. PubMed ID: 31945675
[TBL] [Abstract][Full Text] [Related]
36. Not a benign motor neuron disease: longitudinal imaging captures relentless motor connectome disintegration in primary lateral sclerosis.
Tahedl M; Tan EL; Shing SLH; Chipika RH; Siah WF; Hengeveld JC; Doherty MA; McLaughlin RL; Hardiman O; Finegan E; Bede P
Eur J Neurol; 2023 May; 30(5):1232-1245. PubMed ID: 36739888
[TBL] [Abstract][Full Text] [Related]
37. Gray Matter Volume Changes over the Whole Brain in the Bulbar- and Spinal-onset Amyotrophic Lateral Sclerosis: a Voxel-based Morphometry Study.
Chen ZY; Liu MQ; Ma L
Chin Med Sci J; 2018 Mar; 33(1):20-28. PubMed ID: 29620511
[TBL] [Abstract][Full Text] [Related]
38. Regional thalamic MRI as a marker of widespread cortical pathology and progressive frontotemporal involvement in amyotrophic lateral sclerosis.
Tu S; Menke RAL; Talbot K; Kiernan MC; Turner MR
J Neurol Neurosurg Psychiatry; 2018 Dec; 89(12):1250-1258. PubMed ID: 30049750
[TBL] [Abstract][Full Text] [Related]
39. Evolving diagnostic criteria in primary lateral sclerosis: The clinical and radiological basis of "probable PLS".
Finegan E; Li Hi Shing S; Siah WF; Chipika RH; Chang KM; McKenna MC; Doherty MA; Hengeveld JC; Vajda A; Donaghy C; Hutchinson S; McLaughlin RL; Hardiman O; Bede P
J Neurol Sci; 2020 Oct; 417():117052. PubMed ID: 32731060
[TBL] [Abstract][Full Text] [Related]
40. Cortical thinning trajectories across disease stages and cognitive impairment in amyotrophic lateral sclerosis.
Consonni M; Dalla Bella E; Contarino VE; Bersano E; Lauria G
Cortex; 2020 Oct; 131():284-294. PubMed ID: 32811660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
